• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

B cell drug set to enter phase III testing

March 30, 2011  

Dalfampridine may improve walking ability: phase III results

March 9, 2011  

Vitamin D and UV exposure during pregnancy/postpartum period

January 26, 2011  

EDSS may underrepresent progression

January 12, 2011  

Demyelination reported following HPV vaccination

October 18, 2010  

Need for early, aggressive treatment in RRMS

October 18, 2010  

New data on fingolimod in RRMS

October 18, 2010  

Treatment discontinuations common in CIS

October 15, 2010  

Switching to fingolimod: TRANSFORMS extension study results

October 15, 2010  

TEMSO phase III results for teriflunomide

October 15, 2010  
Previous
35
36
37
38
39
Next

Browse by Topic

  • MS (414)
  • CLINICAL CASES IN MS (16)
  • EPILEPSY (36)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • DMT prescribing in Canada – survey results posted on June 6, 2025
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 2, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions